iRhythm Technologies, Inc. (NASDAQ:IRTC) Files An 8-K Regulation FD Disclosure

iRhythm Technologies, Inc. (NASDAQ:IRTC) Files An 8-K Regulation FD Disclosure
Item 7.01.Regulation FD Disclosure

Story continues below

iRhythm Technologies, Inc. (the “Company”) is furnishing presentation materials included as Exhibit 99.1 to this report to Item 7.01 of Form 8-K. The Company is not undertaking to update this presentation. The information in this report (including Exhibit 99.1) is being furnished to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).

Item 9.01.Financial Statements and Exhibits.

Exhibit No.



Presentation Materials

iRhythm Technologies, Inc. Exhibit
EX-99.1 2 irtc-ex991_17.htm EX-99.1 irtc-ex991_17.pptx.htm J.P. Morgan Healthcare Conference January 2019 Certain data in this presentation was obtained from various external sources,…
To view the full exhibit click here

About iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc. is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its algorithms analyze the amounts of captured heart beat data and a concise report is provided to the patient’s physician. Its ZIO Report produces a higher diagnostic yield and to change patient management.

An ad to help with our costs